A302550 Stock Overview
Engages in the manufactures and supplies of medical devices worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Remed Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,820.00 |
| 52 Week High | ₩4,420.00 |
| 52 Week Low | ₩2,545.00 |
| Beta | 0.41 |
| 11 Month Change | 14.54% |
| 3 Month Change | 15.76% |
| 1 Year Change | 12.02% |
| 33 Year Change | -28.86% |
| 5 Year Change | 33.57% |
| Change since IPO | 22.04% |
Recent News & Updates
Recent updates
Remed Co.,Ltd.'s (KOSDAQ:302550) 43% Price Boost Is Out Of Tune With Revenues
Nov 06
RemedLtd's (KOSDAQ:302550) Profits Appear To Have Quality Issues
Aug 20Would RemedLtd (KOSDAQ:302550) Be Better Off With Less Debt?
Aug 12Investor Optimism Abounds Remed Co.,Ltd. (KOSDAQ:302550) But Growth Is Lacking
Jun 17Shareholder Returns
| A302550 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 0.3% | 6.1% | -2.8% |
| 1Y | 12.0% | 14.9% | -3.4% |
Return vs Industry: A302550 underperformed the KR Medical Equipment industry which returned 14.9% over the past year.
Return vs Market: A302550 exceeded the KR Market which returned -3.4% over the past year.
Price Volatility
| A302550 volatility | |
|---|---|
| A302550 Average Weekly Movement | 9.1% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A302550's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A302550's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 87 | Geun-Yong Lee | remed.kr |
Remed Co.,Ltd. engages in the manufactures and supplies of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as tinnitus, insomnia, dementia, stress, anxiety, etc. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles.
Remed Co.,Ltd. Fundamentals Summary
| A302550 fundamental statistics | |
|---|---|
| Market cap | ₩117.04b |
| Earnings (TTM) | ₩4.86b |
| Revenue (TTM) | ₩23.42b |
24.1x
P/E Ratio5.0x
P/S RatioIs A302550 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A302550 income statement (TTM) | |
|---|---|
| Revenue | ₩23.42b |
| Cost of Revenue | ₩11.08b |
| Gross Profit | ₩12.34b |
| Other Expenses | ₩7.48b |
| Earnings | ₩4.86b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 158.73 |
| Gross Margin | 52.70% |
| Net Profit Margin | 20.76% |
| Debt/Equity Ratio | 35.5% |
How did A302550 perform over the long term?
See historical performance and comparison